Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Trial Status: active
To determine the safety and efficacy of using the drug azeliragon combined with stereotactic radiosurgery. Specifically, to determine if this combination will lead to improved response in the brain (tumor shrinking in size) and overall tumor control (how long tumor remains controlled).